Author

Jizhong Che

Institution: Binzhou Medical University

Observed institution: Binzhou Medical University

OpenAlex ID: A5083172171

PBX1 Participates in Estrogen-mediated Bladder Cancer Progression and Chemo-resistance Affecting Estrogen Receptors

2022 · Yang Zhao, Jizhong Che, et al. · Current Cancer Drug Targets · 16

The application of emerging immunotherapy in the treatment of prostate cancer: progress, dilemma and promise

2025 · Jizhong Che, Yuanyuan Liu, et al. · Frontiers in Immunology · 15

Application and optimization of prostate-specific antigen screening strategy in the diagnosis of prostate cancer: a systematic review

2024 · Zhengchao Zhang, Aimin Tian, et al. · Frontiers in Oncology · 13

Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review)

2024 · Yankai Xu, Gang Zhang, et al. · International Journal of Oncology · 11

Expression of B7 Homolog 1 (B7H1) Is Associated with Clinicopathologic Features in Urothelial Bladder Cancer

2018 · Qingyuan Li, Feng Li, et al. · Medical Science Monitor · 7

Navigating the landscape of targeted therapies for renal cell carcinoma in the era of precision medicine (Review)

2026 · Hongguo Cui, Jingheng Song, et al. · Molecular Medicine Reports

Gut microbiota and its metabolites: Key factors of drug resistance in the treatment of advanced prostate cancer (Review)

2026 · Jingheng Song, Hongguo Cui, et al. · Molecular Medicine Reports

Clinical analysis of percutaneous nephrolithotomy combined with flexible cystoscope in the treatment of complex renal calculi

2014 · Yin‐Xu Wan, Jizhong Che, et al. · Zhonghua miniao waike zazhi

Works count: 8

Citation count: 62

H-index: 5

I10-index: 4